Novamab

About:

Novamab focuses on the research and development of new nanobodies.

Website: http://www.novamab.com

Top Investors: Qiming Venture Partners, Taiyu Investment, Fuho Capital, Jiu Yu Capital, Guosheng Capital

Description:

Novamab focuses on the research and development of new nanobodies. The core members of the team have 15 years of experience in nanobody research and development, and are domestic nanobody "pioneers". At present, they have established an inhaled macromolecular drug research and development platform, an albumin nanobody long-acting platform and a nanobody double-antibody platform, etc., to give full play to nanobody The advantages of antibodies, the development of innovative nanobody drugs such as sprays and eye drops, to solve the pain points of clinical major chronic diseases in terms of administration methods, administration cycles, etc.

Total Funding Amount:

377M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2017-01-01

Founders:

Number of Employees:

51-100

Last Funding Date:

2024-06-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai